575 related articles for article (PubMed ID: 15306840)
1. Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4.
Zhou N; Fang J; Mukhtar M; Acheampong E; Pomerantz RJ
Gene Ther; 2004 Dec; 11(23):1703-12. PubMed ID: 15306840
[TBL] [Abstract][Full Text] [Related]
2. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
3. RNA interference:a potential novel therapeutic combating HIV-1 in the central nervous system.
Pomerantz RJ
Arch Immunol Ther Exp (Warsz); 2004; 52(6):401-9. PubMed ID: 15577741
[TBL] [Abstract][Full Text] [Related]
4. Use of GPR1, GPR15, and STRL33 as coreceptors by diverse human immunodeficiency virus type 1 and simian immunodeficiency virus envelope proteins.
Edinger AL; Hoffman TL; Sharron M; Lee B; O'Dowd B; Doms RW
Virology; 1998 Sep; 249(2):367-78. PubMed ID: 9791028
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
6. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
[TBL] [Abstract][Full Text] [Related]
7. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
8. [RNA interference and its application in inhibiting HIV-1 infection].
Wei L; Liu X; Cao C
Sheng Wu Gong Cheng Xue Bao; 2005 Jul; 21(4):516-9. PubMed ID: 16176084
[TBL] [Abstract][Full Text] [Related]
9. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
[TBL] [Abstract][Full Text] [Related]
10. siRNA-directed inhibition of HIV-1 infection.
Novina CD; Murray MF; Dykxhoorn DM; Beresford PJ; Riess J; Lee SK; Collman RG; Lieberman J; Shankar P; Sharp PA
Nat Med; 2002 Jul; 8(7):681-6. PubMed ID: 12042777
[TBL] [Abstract][Full Text] [Related]
11. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection.
Zaitseva MB; Lee S; Rabin RL; Tiffany HL; Farber JM; Peden KW; Murphy PM; Golding H
J Immunol; 1998 Sep; 161(6):3103-13. PubMed ID: 9743377
[TBL] [Abstract][Full Text] [Related]
12. Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors.
Sabri F; Tresoldi E; Di Stefano M; Polo S; Monaco MC; Verani A; Fiore JR; Lusso P; Major E; Chiodi F; Scarlatti G
Virology; 1999 Nov; 264(2):370-84. PubMed ID: 10562499
[TBL] [Abstract][Full Text] [Related]
13. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
14. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection.
Moyle GJ; Wildfire A; Mandalia S; Mayer H; Goodrich J; Whitcomb J; Gazzard BG
J Infect Dis; 2005 Mar; 191(6):866-72. PubMed ID: 15717260
[TBL] [Abstract][Full Text] [Related]
16. Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells.
Shirazi Y; Pitha PM
J Hum Virol; 1998; 1(2):69-76. PubMed ID: 10195234
[TBL] [Abstract][Full Text] [Related]
17. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing.
Bennasser Y; Le SY; Benkirane M; Jeang KT
Immunity; 2005 May; 22(5):607-19. PubMed ID: 15894278
[TBL] [Abstract][Full Text] [Related]
18. Gene silencing of HIV chemokine receptors using ribozymes and single-stranded antisense RNA.
Qureshi A; Zheng R; Parlett T; Shi X; Balaraman P; Cheloufi S; Murphy B; Guntermann C; Eagles P
Biochem J; 2006 Mar; 394(Pt 2):511-8. PubMed ID: 16293105
[TBL] [Abstract][Full Text] [Related]
19. Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance.
Anderson J; Banerjea A; Akkina R
Oligonucleotides; 2003; 13(5):303-12. PubMed ID: 15000821
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus type 1 replication by siRNA targeted to the highly conserved primer binding site.
Han W; Wind-Rotolo M; Kirkman RL; Morrow CD
Virology; 2004 Dec; 330(1):221-32. PubMed ID: 15527848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
